Avidity Biosciences (RNA)
(Delayed Data from NSDQ)
$46.30 USD
+1.18 (2.62%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $46.29 -0.01 (-0.02%) 4:28 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.76 | 6.27% |
Earnings Summary
For their last quarter, Avidity Biosciences (RNA) reported earnings of -$0.79 per share, beating the Zacks Consensus Estimate of $-0.81 per share. This reflects a positive earnings surprise of 2.47%. Look out for RNA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.76 per share, reflecting a year-over-year decrease of 15.15%.
Earnings History
Price & Consensus
Zacks News for RNA
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
RNA: What are Zacks experts saying now?
Zacks Private Portfolio Services